|
ZNF322B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.349500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.746220E-01 |
| Normal-vs-Stage2 |
6.576200E-01 |
| Normal-vs-Stage3 |
7.564700E-03 |
| Normal-vs-Stage4 |
1.121860E-02 |
| Stage1-vs-Stage2 |
7.001200E-01 |
| Stage1-vs-Stage3 |
8.566300E-02 |
| Stage1-vs-Stage4 |
1.063240E-01 |
| Stage2-vs-Stage3 |
2.220800E-01 |
| Stage2-vs-Stage4 |
2.084200E-01 |
| Stage3-vs-Stage4 |
8.907400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.250200E-02 |
| Normal-vs-AfricanAmerican |
3.277600E-01 |
| Normal-vs-Asian |
8.428200E-01 |
| Caucasian-vs-AfricanAmerican |
5.019400E-01 |
| Caucasian-vs-Asian |
3.613600E-01 |
| AfricanAmerican-vs-Asian |
5.158200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.583800E-02 |
| Normal-vs-Female |
2.606000E-01 |
| Male-vs-Female |
1.113960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.105700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.256220E-01 |
| Normal-vs-Age(61-80Yrs) |
7.675800E-02 |
| Normal-vs-Age(81-100Yrs) |
8.428300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.887410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.917590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.240800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.337200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.663600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.928000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.130010E-01 |
| Normal-vs-Grade 2 |
4.672800E-01 |
| Normal-vs-Grade 3 |
4.039600E-03 |
| Normal-vs-Grade 4 |
1.849790E-04 |
| Grade 1-vs-Grade 2 |
7.101600E-02 |
| Grade 1-vs-Grade 3 |
2.647800E-02 |
| Grade 1-vs-Grade 4 |
7.743100E-03 |
| Grade 2-vs-Grade 3 |
1.326360E-02 |
| Grade 2-vs-Grade 4 |
2.575000E-04 |
| Grade 3-vs-Grade 4 |
6.248200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.022800E-01 |
| Normal-vs-ccB subtype |
1.657270E-03 |
| ccA subtype-vs-ccB subtype |
1.430020E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.942970E-01 |
| Normal-vs-N1 |
2.604800E-01 |
| N0-vs-N1 |
6.625000E-01 |
|
|
